Cardiff Oncology, Inc. · MUN:XE7C
Cardiff Oncology, Inc. shareholders
As of Sep 30, 2026, 73 institutions reported holding Cardiff Oncology, Inc., 23.1% of its shares. Largest: Vanguard, Laurion Capital Management LP and Pfizer Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cardiff Oncology, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 3.37M | 4.3% | +38,496 | Nov 13, 2026 |
| Laurion Capital Management LP | 3.1M | 4.0% | no change | Oct 30, 2026 |
| Pfizer Inc | 2.41M | 3.1% | no change | Nov 12, 2026 |
| Franklin Templeton | 1.21M | 1.5% | no change | Nov 12, 2026 |
| BlackRock | 936K | 1.2% | −36,980 | Nov 13, 2026 |
| Blair William & Co | 917K | 1.2% | +4,462 | Nov 10, 2026 |
| Geode Capital | 840K | 1.1% | +19,806 | Nov 6, 2026 |
| GoalVest Advisory LLC | 687K | 0.88% | new | Oct 2, 2026 |
| Gsa Capital Partners LLP | 538K | 0.69% | +364K | Nov 16, 2026 |
| Balyasny Asset Management L.P. | 382K | 0.49% | new | Nov 16, 2026 |